today announced the completion of recruitment in its Phase 2 TrIuMPH (Treating IBS with an Intestinal Microbiota Product for Health) trial assessing the safety, tolerability and efficacy of EBX-102-02 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback